About: Malika Hamdane

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Malika Hamdane Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher ORCID ID = 0000-0001-7971-8696

Attributes	Values
rdf:type	Item
description	forskare (sv) 연구원 (ko) araştırmacı (tr) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) onderzoeker (nl) researcher ORCID ID = 0000-0001-7971-8696 (en)
rdfs:label	M Hamdane (nl) M Hamdane (ast) Malika Hamdane (en)
skos:prefLabel	M Hamdane (nl) M Hamdane (ast) Malika Hamdane (en)
name	M Hamdane (nl) M Hamdane (ast) Malika Hamdane (en)
given name	wds:Q58492744-8264BE4C-90AF-41FB-B9CF-A6F06B37653E
given name	Malika
instance of	wds:Q58492744-832B45B4-78DE-4DC3-9883-70201C91C97D
instance of	Homo sapiens
occupation	wds:Q58492744-1010E49B-E56C-4581-8065-08D100442FA3
employer	wds:Q58492744-B62558FB-4D6A-48D3-9229-971BC060F7A4 wds:Q58492744-C23472AD-3747-4057-91EA-666672AB141F wds:Q58492744-D8FB1222-CC04-4FD7-8CD6-777B3209422D
sex or gender	wds:Q58492744-91f11aa8-77e8-4517-9bf4-5d77c420fa40
ISNI	wds:Q58492744-B865C36A-06E1-4346-9223-3FCD9B171C28
VIAF ID	wds:Q58492744-403C30CC-9B4A-4611-8AB9-CD4BCF105EA9
IdRef ID	wds:Q58492744-B74EEDBA-FA40-4902-98B1-97786555D0E9
VIAF ID	http://viaf.org/viaf/192927684
IdRef ID	http://www.idref.fr/118804960/id
occupation	researcher
employer	Free University of Brussels French National Institute of Health and Medical Research Lille North of France University
sex or gender	female organism
ISNI	000000041926521X
VIAF ID	192927684
IdRef ID	118804960
ORCID iD	wds:Q58492744-F8F1E08A-F423-43F2-9A23-05C2EF8D1D63
ORCID iD	https://orcid.org/0000-0001-7971-8696
ORCID iD	0000-0001-7971-8696
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58492744
is author of	Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis Intracellular pH regulates amyloid precursor protein intracellular domain accumulation. Determination of the human c-Abl consensus DNA binding site From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease? NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model. Progressive age-related cognitive decline in tau mice. Pin1 allows for differential Tau dephosphorylation in neuronal cells p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis. Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies. Proteasome inhibition and Tau proteolysis: an unexpected regulation. Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis? Two-dimensional electrophoresis of tau mutants reveals specific phosphorylation pattern likely linked to early tau conformational changes. Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice. The complex p25/Cdk5 kinase in neurofibrillary degeneration and neuronal death: the missing link to cell cycle. Biochemistry of Tau in Alzheimer's disease and related neurological disorders. NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology? Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolism. PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology. MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway. Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblotting. Erratum: A2A adenosine receptor deletion is protective in a mouse model of Tauopathy Cellular contaminants of adeno-associated virus vector stocks can enhance transduction. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy Hippocampal BDNF expression in a tau transgenic mouse model. From tau phosphorylation to tau aggregation: what about neuronal death? Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities. Tau deletion promotes brain insulin resistance The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior Highly successful therapeutic vaccinations combining dendritic cells and tumor cells secreting granulocyte macrophage colony-stimulating factor. Pin1: a therapeutic target in Alzheimer neurodegeneration Variation of endothelial nitric oxide synthase synthesis in the median eminence during the rat estrous cycle: an additional argument for the implication of vascular blood vessel in the control of GnRH release. Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities. The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease. [Tau story: from frontotemporal dementia to other tauopathies] [Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?]. Role and expression of CD40 on human retinal pigment epithelial cells
is author of	wds:Q27683399-C32E6715-3D14-4F1F-8F7C-D1FFA07E7D02 wds:Q35634105-DDE3AEED-DB9A-4B11-97C8-66C4050A3208 wds:Q57566967-E959803A-3AF6-4D46-A660-D486E401464A wds:Q37775662-52CF88E5-E496-4AB9-8824-5A95F7C0D307 wds:Q40675753-E71AE936-422C-4E15-97C4-1B2385AD228A wds:Q41755392-4762A11A-9003-434A-8F51-8716B4A5E32D wds:Q57896998-5099D275-BA73-4C75-B7A5-110C36317F41 wds:Q30478477-98D31867-E452-463B-B70B-85E08A3CC688 wds:Q53419341-38E793AE-976F-4968-AD99-15EBACACCACB

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software